Although viruses can induce rheumatic diseases, the impact of SARS-CoV-2, the virus
behind COVID-19, on the development of systemic rheumatic disease is unclear. COVID-19 …

Comment www. thelancet. com/rheumatology Vol 3 January 2021 e7 before the onset of
clinical symptoms; and the presence of human leukocyte anti gen (HLA)-DR alleles that …

Comment e676 www. thelancet. com/rheumatology Vol 3 October 2021 8375 [90· 1%]
women and 893 [9· 6%] men) between April 3 and May 8, 2020. The most frequent …

In December, 2019, an outbreak of the novel coronavirus (SARS-CoV-2) that causes
coronavirus dis ease 2019 (COVID-19) occurred in Wuhan, China, 1 and soon spread all …

We read with interest the studies by Renaud Felten and colleagues1 and Laura Boekel and
colleagues2 published in The Lancet Rheumatology, which both contribute essential …

The pattern and mechanism of inflammation in COVID-19 remains unclear, although
multiple cytokines are elevated in severe infection. 1 An early report found that some …

The impact of COVID-19 from the perspective of disease severity and overall mortality
appears to be subsiding; however, what the future holds in terms of the post-COVID …

The current outbreak of COVID19, caused by severe acute respiratory syndrome
coronavirus 2 (SARSCoV2), is characterised by clinical signs and symptoms such as …

At the 2019 American College of Rheumatology (ACR) annual meeting, we chaired a
session entitled “Frontiers and Opportunities in Global Rheumatology Research”, which was …

There is a continuous debate about the risks of increased incidence of COVID-19 in
vulnerable patient groups, which includes patients with rheumatic diseases and especially …